Accelerating biologics: From final DNA to Phase I in under 9 months
Accelerating biologics: From final DNA to Phase I in under 9 months
Originally presented at BIO International 2025, this webinar explores how Path to IND helps biotech companies move from DNA to first-in-human Phase I clinical trials in as little as nine months.*

Added Date:

2025-08-25

Filters:

Filter Category Filter Values
Specialty
  • Quick to Care
Month
  • August
Capability
  • Biologics
Year
  • 2025
Language
  • Korean
Asset Type
  • Webinar on-demand
Country
  • Korea
Region
  • Asia Pacific (APAC)
Market Category
  • Large molecule
Content Category
  • Collateral

Country Availability:


()

Gated Form:

None Set